Residential exposure to petrochemicals is associated with an elevated risk of leukemia among adults in their 20s, according to a new report.

Previous studies have linked workplace exposure to petrochemicals…

An experimental drug targeted to a cancer-causing mechanism within the cell may be a powerful weapon against deadly multiple myeloma.

So concludes a team of researchers at…

Children with cancer who develop anemia during chemotherapy can benefit from a weekly dose of erythropoietin (EPO), according to researchers at St. Jude Children’s Research Hospital. The drug reduces the…

Researchers recently discovered that a mutation in the JAK2 gene is responsible for the majority of cases of three rare kinds of chronic leukemia, all of which are resistant…

Older adults who are anemic have an increased risk of hospitalization and death, according to a report from Canada.

Anemia occurs when there is a drop in the blood’s ability…

Scientists in Hong Kong believe they have uncovered the trigger for leukemia, a cancer of the blood that afflicts millions worldwide.

The findings could pave the way for the design of…

An international research study involving the University of Nebraska Medical Center, the National Cancer Institute and 10 other institutions has successfully identified the gene expression signature for Burkitt lymphoma.

The discovery,…

Dasatinib, an experimental drug under development by Bristol-Myers Squibb, reverses the signs and symptoms of patients whose chronic myeloid leukemia has failed to respond to Gleevec, which is considered the…

Promising findings were reported today showing that the combination of thalidomide and dexamethasone (Thal/Dex) when used as initial therapy for multiple myeloma, slowed disease progression almost two-fold compared…

ODC Therapy, Inc., a cancer immunotherapy company started by Baylor Health Care System, announced today that data from an ongoing Phase 2 trial of its dendritic cell vaccine for…

Celgene Inc. said on Sunday its cancer drug Thalomid improved survival by a significant amount in elderly patients with multiple myeloma, a form of blood cancer.

Data presented at the annual…

Children living near nuclear plants in France do not have an increased risk of leukemia, a new study confirms.

Most studies that have examined cancer risk near nuclear installations…

New clues to why some kinds of leukemia are more aggressive and deadly than others are coming from research examining the types of genetic damage…

Investigators at St. Jude Children’s Research Hospital have used mouse models to determine why some forms of acute lymphoblastic leukemia (ALL) are extremely aggressive and resist a drug that is…

A study led by researchers from the Howard Hughes Medical Institute has found that dasatinib provides significant benefit in chronic myeloid leukemia (CML) patients resistant to Gleevec®…

Hodgkin’s disease survivors face a more than six-fold increased risk of developing acute myeloid leukemia (AML), which is highest in the 10 years after Hodgkin’s diagnosis, a large study shows.

In a study of more than 3,000 older Australians, those with a higher white blood cell count, a sign of inflammation, were more likely to die of cancer,…